Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?

J Neurol Neurosurg Psychiatry. 2005 Jun;76(6):775-9. doi: 10.1136/jnnp.2003.033258.

Abstract

Objective: High frequency stimulation of the subthalamic nucleus (STN) dramatically decreases motor disability in patients with Parkinson"s disease (PD), but has been reported to aggravate apathy. The aim of this study was to analyse the effect of STN stimulation on motivation and reward sensitivity in a consecutive series of PD patients.

Methods: Apathy and reward sensitivity (Apathy Scale, Stimulus-Reward Learning, Reversal, Extinction, and Gambling tasks) were assessed in 18 PD patients treated by bilateral STN stimulation ("on" and "off" conditions) compared with 23 matched patients undergoing long term treatment with levodopa ("on" and "off" conditions).

Results: Apathy decreased under both STN stimulation and levodopa treatment, whereas explicit and implicit stimulus reward learning was unchanged.

Conclusions: Bilateral STN stimulation in PD patients does not necessarily have a negative effect on motivation and reward sensitivity and can even improve apathy provided patients have been appropriately selected for neurosurgery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Deep Brain Stimulation* / adverse effects
  • Deep Brain Stimulation* / instrumentation
  • Deep Brain Stimulation* / statistics & numerical data
  • Extinction, Psychological
  • Female
  • Functional Laterality / physiology*
  • Humans
  • Levodopa / therapeutic use
  • Male
  • Middle Aged
  • Mood Disorders / diagnosis
  • Mood Disorders / economics
  • Mood Disorders / epidemiology*
  • Motivation*
  • Neurosurgical Procedures
  • Parkinson Disease / epidemiology
  • Parkinson Disease / surgery
  • Parkinson Disease / therapy*
  • Reward
  • Severity of Illness Index
  • Subthalamic Nucleus / physiology*
  • Subthalamic Nucleus / surgery

Substances

  • Antiparkinson Agents
  • Levodopa